NIH-funded research R01 grant

Understanding how HPV causes head and neck cancer

Official title: Dissecting NF-kB pathway in HPV-associated head and neck cancer

Funded at Univ of North Carolina Chapel Hill · NIH-10992680 · Data updated 2026-11-12

This study is looking at how the HPV virus might lead to certain throat cancers and how a specific signaling pathway in our cells could help us find out which patients with HPV are more likely to do well with gentler treatments, making their experience easier and less harsh.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startMarch 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$509,676
NIH project number5R01DE031297-03
Project IDNIH-10992680 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with HPV-associated head and neck squamous cell carcinoma.

Less likely to help

Patients with head and neck cancer not associated with HPV or those with other types of cancers may not benefit from this research.

What this research studies

This research investigates the mechanisms by which the human papillomavirus (HPV) contributes to head and neck squamous cell carcinoma (HNSCC). It focuses on the NF-kB signaling pathway, which may play a crucial role in the cancer's development and response to treatment. By analyzing data from multiple patient cohorts, the study aims to identify biomarkers that can predict which HPV+ patients are likely to benefit from less aggressive treatment options. This could help reduce the side effects associated with current therapies.

Why it matters

Potential benefit: If successful, this research could lead to more personalized treatment plans for HPV+ head and neck cancer patients, potentially reducing treatment-related side effects.

How similar studies have gone: Previous research has shown promising results in understanding the role of the NF-kB pathway in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Yarbrough, Wendell G — Univ of North Carolina Chapel Hill
  • Study coordinator: Yarbrough, Wendell G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.